Endoscopic treatment for gastroesophageal reflux disease
Not Applicable
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0003938
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Patients with gastroesophageal reflux disease who are not able to maintain pharmacotherapy or whose pharmacotherapy is inadequate and have a duration of six months or more
Exclusion Criteria
1) Hiatal hernia more than 2 cm in length with upper endoscopic examination
2) LA-C or LA-D reflux esophagitis
3) Barrett`s esophagus >2cm
4) Esophageal varix
5) Gastric outlet obstruction
6) Spastic motility disorder such as achalasia, diffuse esophageal spasm, and Jack hammer esophagus with esophageal manometry
7) Coagulopathy (Platelet < 50,000, PT < 60%, unable to stop antiplatelet or anticoagulant such as aspirin/warfarin)
8) Pregnancy
9) Anatomic alteration due to previous esophageal or gastric surgery
10) Body mass index > 35
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method GERD symptom improvement;stricture
- Secondary Outcome Measures
Name Time Method 24 hour pH monitoring